Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Danaher : to Present at Evercore ISI HealthCONx Conference

11/25/2020 | 09:56am EST

WASHINGTON - Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020 at 8:50 a.m. ET.

The audio will be simultaneously webcast on www.danaher.com.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of more than 67,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

Contact:

Matthew E. Gugino

Tel: (202) 828-0850

Fax: (202) 828-0860

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about DANAHER CORPORATION
01/14DANAHER : Credit Suisse Adjusts Danaher's Price Target to $264 from $260, Keeps ..
MT
01/14CEPHEID : Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Co..
AQ
01/13DANAHER : Expects 39% Annual Revenue Growth in Q4
MT
01/13DANAHER : Expects 38.5% Increase in 4Q Revenue, Raises Core Revenue Guidance
DJ
01/13DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
01/13DANAHER : CEO To Comment On Financial Performance
PR
01/07DANAHER : Schedules Fourth Quarter 2020 Earnings Conference Call
PR
01/07DANAHER : To Present At J.P. Morgan Healthcare Conference
PR
2020DANAHER : Zacks Investment Research Adjusts Price Target for Danaher to $255 Fro..
MT
2020DANAHER CORPORATION : Ex-dividend day for
FA
More news
Financials (USD)
Sales 2020 22 123 M - -
Net income 2020 3 396 M - -
Net Debt 2020 15 996 M - -
P/E ratio 2020 51,0x
Yield 2020 0,31%
Capitalization 168 B 168 B -
EV / Sales 2020 8,33x
EV / Sales 2021 7,10x
Nbr of Employees 60 000
Free-Float 74,1%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 253,50 $
Last Close Price 236,75 $
Spread / Highest target 18,3%
Spread / Average Target 7,07%
Spread / Lowest Target -41,7%
EPS Revisions
Managers and Directors
NameTitle
Rainer M. Blair President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Jose Carlos Gutiérrez Ramos Chief Scientific Officer & Senior Vice President
Alan G. Spoon Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER CORPORATION6.58%168 182
THERMO FISHER SCIENTIFIC8.02%199 412
INTUITIVE SURGICAL, INC.-4.85%91 508
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-0.02%82 347
SIEMENS HEALTHINEERS AG3.17%56 007
ILLUMINA, INC.1.72%54 947